Comments
Loading...

Invesco Biotechnology & Genome ETF

PBEARCA
Logo brought to you by Benzinga Data
$70.84
0.741.06%
At Close: -
$65.50
-5.34-7.54%
After Hours: Jun 26, 7:00 AM EDT
15 minutes delayed
Number of Stock Holdings
30
Number of Bond Holdings
-
Total Holdings
33
Number of ETFs
-

Invesco Biotechnology & Genome ETF (ARCA:PBE), Top Holdings

Invesco Biotechnology & Genome ETF (ARCA: PBE)

TickerNameShare %
BMRNBiomarin Pharmaceutical Inc.5.39%
REGNRegeneron Pharmaceuticals, Inc.5.27%
GILDGilead Sciences Inc5.23%
INCYIncyte5.16%
VRTXVertex Pharmaceuticals Inc5.11%
AMGNAmgen Inc.5.07%
ILMNIllumina Inc4.97%
NBIXNeurocrine Biosciences Inc4.78%
IONSIonis Pharmaceuticals Inc3.37%
HALOHalozyme Therapeutics Inc3.23%

FAQ

Q

How has PBE ETF performed?

A

The PBE ETF is currently trading at $65.50, which represents a -6.56% change. Over the past 52 weeks, the ETF has traded as high as $70.70 and as low as $52.47.

Q

What is the expense ratio for PBE?

A

The expense ratio of PBE is NA%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for PBE?

A

The total Assets Under Management (AUM) for PBE is 271.00M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for PBE?

A

PBE follows a Mid Cap Growth investment style.

Q

What are the top holdings for PBE?

A

The top holdings of PBE include: BMRN (5.39%), REGN (5.27%), GILD (5.23%), INCY (5.16%), VRTX (5.11%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for PBE?

A

Average daily volume data for PBE is currently not available.